An HSV-2 based oncolytic virus can function as an attractant to guide migration of adoptively transferred T cells to tumor sites

Adoptive T-cell therapy has shown promises for cancer treatment. However, for treating solid tumors, there is a need for improving the ability of the adoptively transferred T cells to home to tumor sites. We explored the possibility of using an oncolytic virus derived from HSV-2, which can actively...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Xinping, Rivera, Armando, Tao, Lihua, Zhang, Xiaoliu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2014
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359264/
https://www.ncbi.nlm.nih.gov/pubmed/25460506

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359264/
https://www.ncbi.nlm.nih.gov/pubmed/25460506

Ejemplares similares